ATRX and central nervous system cancer: Interestingly, Hewitt et al. compared approaches for predicting the 2021 WHO glioma subtypes, and reported that first predicting IDH, 1p/19q, and ATRX status, and then inferring subtypes from these predictions performed overall better than an end-to-end approach41.